Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Tamiflu oseltamivir: Marketed

Partner F. Hoffmann-La Roche Ltd. (SWX:ROCZ, Basel, Switzerland) published in The Lancet

Read the full 129 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE